National Health (Botulinum Toxin Program) Special Arrangement Amendment Instrument 2017 (No. 1) (PB 8 of 2017) (Cth)

PB 8 of 2017

National Health (Botulinum Toxin Program) Special Arrangement Amendment Instrument 2017 (No. 1)

I, Julianne Quaine, as delegate of the Minister for Health, make the following instrument.

Dated 23 February 2017

Julianne Quaine

Assistant Secretary

Pharmaceutical Access Branch

Pharmaceutical Benefits Division

Department of Health

Contents

1............ Name............................................................................................................................. 1

2............ Commencement............................................................................................................. 1

3............ Authority....................................................................................................................... 1

4............ Schedules...................................................................................................................... 1

Schedule 1—Amendments  2

National Health (Botulinum Toxin Program) Special Arrangement 2015  2

1  Name

(1)  This instrument is the National Health (Botulinum Toxin Program) Special Arrangement Amendment Instrument 2017 (No. 1).

(2)  This instrument may also be cited as PB 8 of 2017.

2  Commencement

(1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1.  The whole of this instrument	1 March 2017.	1 March 2017

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

This instrument is made under subsection 100(2) of the National Health Act 1953.

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Botulinum Toxin Program) Special Arrangement 2015

1  At the end of section 6

Add:

(4)  For the purposes of paragraph 19(2)(a) of the Regulations, a pharmaceutical benefit to be supplied to a person in accordance with this Special Arrangement is taken to be the same as, or equivalent to, another pharmaceutical benefit to be supplied to that person in accordance with this Special Arrangement only if:

(a)  the prescriptions for the supply of both benefits relate to moderate to severe spasticity of the upper limb (whether or not following a stroke); or

(b)  the prescriptions for the supply of both benefits relate to urinary incontinence; or

(c)  the prescriptions for the supply of both benefits relate to spasmodic torticollis; or

(d)  the prescriptions for the supply of both benefits relate to dynamic equinus foot deformity; or

(e)  the prescriptions for the supply of both benefits relate to blepharospasm; or

(f)  the prescriptions for the supply of both benefits relate to hemifacial spasm; or

(g)  the prescriptions for the supply of both benefits relate to chronic migraine; or

(h)  the prescriptions for the supply of both benefits relate to severe primary axillary hyperhidrosis; or

(i)  the prescriptions for the supply of both benefits:

(i) are written in circumstances, determined by the Minister under paragraph 85(7)(b) of the Act, that have the same circumstances code (within the meaning of the Minister’s determination); and

(ii)  are not prescriptions of a kind referred to in paragraphs (a) to (h) of this subsection.